Ultragenyx Pharmaceutical Inc. (RARE)

NASDAQ: RARE · IEX Real-Time Price · USD

42.55

-0.23 (-0.54%)

At close: Jul 19, 2024, 4:00 PM

42.37

-0.18 (-0.42%)

Pre-market: Jul 22, 2024, 8:54 AM EDT

Ultragenyx Pharmaceutical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2011
Net Income	-613.35	-606.64	-707.42	-454.03	-186.57	-402.73	Upgrade
Depreciation & Amortization	29.62	26.01	18.22	13.24	12.26	8.54	Upgrade
Share-Based Compensation	140.2	135.23	130.38	104.95	85.74	82	Upgrade
Other Operating Activities	-65.13	-29.4	178.36	-2.86	-43.65	-33.19	Upgrade
Operating Cash Flow	-508.67	-474.81	-380.47	-338.7	-132.22	-345.38	Upgrade
Capital Expenditures	-22.44	-44.27	-116.12	-73.09	-43.91	-24.83	Upgrade
Acquisitions	0	0	-75.03	0	0	0	Upgrade
Change in Investments	189.24	219.82	-69.66	-121.34	-129.66	11.79	Upgrade
Other Investing Activities	-15.66	-7.55	-30.84	-0.94	-5.56	-	Upgrade
Investing Cash Flow	151.13	168	-291.65	-195.37	-179.12	-13.04	Upgrade
Share Issuance / Repurchase	388.86	388.17	10.81	119.04	600.51	365.07	Upgrade
Other Financing Activities	-0.06	-0.03	490.4	-0.49	-0.24	314.23	Upgrade
Financing Cash Flow	388.81	388.14	501.21	118.55	600.27	679.31	Upgrade
Exchange Rate Effect	-0.43	0.46	-1.08	-1.19	1.12	-0.17	Upgrade
Net Cash Flow	30.84	81.8	-171.98	-416.71	290.05	320.72	Upgrade
Free Cash Flow	-531.11	-519.07	-496.59	-411.79	-176.13	-370.22	Upgrade
Free Cash Flow Margin	-120.00%	-119.53%	-136.68%	-117.18%	-64.98%	-356.96%	Upgrade
Free Cash Flow Per Share	-6.30	-7.06	-7.10	-6.07	-2.90	-6.54	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).